News Janssen drug approved in combination against myeloma FDA backs Darzalex in multiple myeloma second line.
News Janssen takes aim at AbbVie with psoriasis drug Janssen has filed its psoriasis injection guselkumab in the US, one of a crop of new drugs it hopes will each exceed $1 billion in sales.
News EU approval for Crohn's another boost for fast-growing Stela... J&J unit's blockbuster gets new use.
Views & Analysis Digital Health Round-up – pharma to build Moonshot database,... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Takeda plans filings for Sotyktu rival on new psoriasis data Takeda intends to file for approval of its oral psoriasis therapy zasocitinib next year, with Bristol Myers Squibb's Sotyktu in its sights.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
